Clinical Trials on Hidradenitis Suppurativa (HS) in Norway
Total 10 results
-
AbbVieCompletedHidradenitis Suppurativa (HS)United States, Belgium, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Ireland, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Sweden, Turkey, United Kingdom
-
University Hospital of North NorwayThe Royal Norwegian Ministry of Health; Hidrosis Clinic, Stockholm, SwedenCompletedHidradenitis SuppurativaNorway
-
Pharma Holdings ASUniversity Hospital of North NorwayCompleted
-
Boehringer IngelheimCompletedHidradenitis SuppurativaNorway, United States, Australia, Germany, Netherlands, Italy, Canada, Czechia, France, Poland, Spain, Belgium
-
Boehringer IngelheimCompletedHidradenitis SuppurativaAustralia, United States, Germany, Netherlands, Italy, Canada, Czechia, France, Norway, Poland, Spain
-
UCB Biopharma SRLCompletedHidradenitis SuppurativaUnited States, Australia, Belgium, Denmark, Germany, Greece, Norway, Russian Federation
-
UCB Biopharma SRLCompletedHidradenitis SuppurativaUnited States, Australia, Belgium, Canada, Denmark, France, Germany, Greece, Israel, Italy, Netherlands, Norway, Spain, Switzerland, Turkey
-
ChemoCentryxCompletedHidradenitis Suppurativa | Acne InversaUnited States
-
University of OsloOslo University Hospital; Sunnaas Rehabilitation HospitalRecruitingFatigue | Cognitive Dysfunction | Brain AbscessNorway
-
Durata Therapeutics Inc., an affiliate of Allergan...CompletedAbscess | Cellulitis | Surgical Site Infection | Wound InfectionUnited States, Bulgaria, Estonia, Hungary, Israel, Korea, Republic of, Latvia, Lithuania, Romania, Russian Federation, Slovakia, South Africa, Taiwan, Ukraine